Nonmedical Use of Prescription Opioids among Pregnant U.S. Women
- PMID: 28408072
- PMCID: PMC5435501
- DOI: 10.1016/j.whi.2017.03.001
Nonmedical Use of Prescription Opioids among Pregnant U.S. Women
Abstract
Objectives: Nonmedical use of opioids during pregnancy is associated with adverse outcomes for women and infants, making it a prominent target for prevention and identification. Using a nationally representative sample, we determined characteristics of U.S. pregnant women who reported prescription opioid misuse in the past year or during the past month.
Methods: We used data from the National Survey on Drug Use and Health (2005-2014) in a retrospective analysis. The sample included 8,721 (weighted n = 23,855,041) noninstitutionalized women, ages 12 to 44, who reported being pregnant when surveyed. Outcomes were nonmedical use of prescription opioid medications during the past 12 months and during the past 30 days. Multivariable logistic regression models were created to determine correlates of nonmedical opioid use after accounting for potential confounding variables.
Results: Among pregnant women in the United States, 5.1% reported nonmedical opioid use in the past year. In adjusted models, depression or anxiety in the past year was strongly associated with past year nonmedical use (adjusted odd ratio [AOR], 2.15; 95% CI, 1.52-3.04), as were past year use of alcohol (AOR, 1.56; 95% CI, 1.11-2.17), tobacco (AOR, 1.72; 95% CI, 1.17-2.53), and marijuana (AOR, 3.44; 95% CI, 2.47-4.81). Additionally, 0.9% of U.S. pregnant women reported nonmedical opioid use in the past month. Past year depression or anxiety and past month use of alcohol, tobacco, and marijuana each independently predicted past month nonmedical use.
Conclusions: Characteristics associated with nonmedical opioid use by pregnant women reveal populations with mental illness and co-occurring substance use. Policy and prevention efforts to improve screening and treatment could focus on the at-risk populations identified in this study.
Copyright © 2017 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.Prev Med. 2019 Apr;121:94-98. doi: 10.1016/j.ypmed.2019.02.018. Epub 2019 Feb 11. Prev Med. 2019. PMID: 30763631 Free PMC article.
-
Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100. doi: 10.1016/j.drugalcdep.2013.01.007. Epub 2013 Feb 12. Drug Alcohol Depend. 2013. PMID: 23410617
-
Correlates of Nonmedical Prescription Opioid Use Among U.S. Adolescents.Am J Prev Med. 2019 Nov;57(5):e175-e179. doi: 10.1016/j.amepre.2019.05.006. Epub 2019 Sep 26. Am J Prev Med. 2019. PMID: 31564603
-
The burden of the nonmedical use of prescription opioid analgesics.Pain Med. 2009 Jul;10 Suppl 2:S89-100. doi: 10.1111/j.1526-4637.2009.00668.x. Pain Med. 2009. PMID: 19691688 Review.
-
Prescription opioid misuse among university students: A systematic review.J Am Coll Health. 2022 May-Jun;70(4):1119-1137. doi: 10.1080/07448481.2020.1786095. Epub 2020 Aug 11. J Am Coll Health. 2022. PMID: 32780647
Cited by
-
Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy - 34 U.S. Jurisdictions, 2019.MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):897-903. doi: 10.15585/mmwr.mm6928a1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32673301 Free PMC article.
-
Health harms of non-medical prescription opioid use: A systematic review.Drug Alcohol Rev. 2022 May;41(4):941-952. doi: 10.1111/dar.13441. Epub 2022 Apr 18. Drug Alcohol Rev. 2022. PMID: 35437841 Free PMC article.
-
Self-regulation and emotional reactivity in infants with prenatal exposure to opioids and alcohol.Early Hum Dev. 2020 Sep;148:105119. doi: 10.1016/j.earlhumdev.2020.105119. Epub 2020 Jul 2. Early Hum Dev. 2020. PMID: 32679473 Free PMC article.
-
A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse.Am J Drug Alcohol Abuse. 2023 May 4;49(3):269-282. doi: 10.1080/00952990.2023.2201944. Epub 2023 May 6. Am J Drug Alcohol Abuse. 2023. PMID: 37148274 Free PMC article. Review.
-
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.J Subst Abuse Treat. 2022 Sep;140:108800. doi: 10.1016/j.jsat.2022.108800. Epub 2022 May 10. J Subst Abuse Treat. 2022. PMID: 35577664 Free PMC article.
References
-
- ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology. 2012;119(5):1070–6. http://doi.org/10.1097/AOG.0b013e318256496e. - DOI - PubMed
-
- AGOG Committee Opinion No. 473: substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist. Obstetrics and Gynecology. 2011;117(1):200–1. http://doi.org/10.1097/AOG.0b013e31820a6216. - DOI - PubMed
-
- Beronio K, Po R, Skopec L, Glied S. Affordable Care Act Will Expand Mental Health and Substance Use Disorder Benefits and Parity Protections for 62 Million Americans. ASPE Research Brief. 2013 Retrieved from http://aspe.hhs.gov/report/affordable-care-act-expands-mental-health-and....
-
- Bessa MA, Mitsuhiro SS, Chalem E, Barros MM, Guinsburg R, Laranjeira R. Underreporting of use of cocaine and marijuana during the third trimester of gestation among pregnant adolescents. Addictive Behaviors. 2010;35(3):266–9. http://doi.org/10.1016/j.addbeh.2009.10.007. - DOI - PubMed
-
- Creanga Aa, Sabel JC, Ko JY, Wasserman CR, Shapiro-Mendoza CK, Taylor P, … Paulozzi LJ. Maternal Drug Use and Its Effect on Neonates. Obstetrics & Gynecology. 2012;119(5):924–933. http://doi.org/10.1097/AOG.0b013e31824ea276. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous